Compressible and free-flow co-agglomerates of mannitol and granular starch
US-9937131-B2 · Apr 10, 2018 · US
US10828256B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10828256-B2 |
| Application number | US-201615745364-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 15, 2016 |
| Priority date | Jul 17, 2015 |
| Publication date | Nov 10, 2020 |
| Grant date | Nov 10, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to mannitol granules that are of use for the preparation of tablets by direct compression, which do not require a small amount of lubricant in order to be processed. The present invention also relates to a process for preparing such granules. The present invention also encompasses pulverulent compositions comprising these granules, and also direct compression processes using these pulverulent compositions. Finally, the present invention relates to tablets composed of these pulverulent compositions.
Opening claim text (preview).
The invention claimed is: 1. Non-spherical granules of microcrystalline mannitol, comprising: mannitol is both in α crystalline form and in β crystalline form, with a α/β ratio between 10/90 and 90/10; wherein said non-spherical granules of microcrystalline mannitol are essentially free of granular starch; have a volume mean diameter D4,3 of from 60 to 250 μm; and have a bulk density of at least 465 g/l; and have a specific surface area greater than 0.75 m 2 /g. 2. The granules according to claim 1 , wherein the α/β ratio is from 15/85 to 85/15. 3. The granules according to claim 1 , wherein the volume mean diameter D4,3 is greater than 80 μm. 4. The granules according to claim 1 the bulk density is at least 470 g/l. 5. The granules according to claim 1 , the specific surface area is greater than 0.80 m 2 /g. 6. The granules according to claim 1 , wherein the granules have a tabletability of between 50 and 500 N. 7. The granules according to claim 1 , wherein the granules have a flow grade of from 3 to 15 seconds. 8. A process for preparing mannitol granules with α crystalline and β crystalline forms, consisting of: preparing a mannitol solution; feeding the solution to a multistage spray-dryer tower comprising of a cylindrical lower part defining a static fluidized bed and inlet, a frustoconical chamber, and a cylindrical upper part with a roof comprising a feed inlet and tower outlets through which fines are removed, recycling the fines to the tower; and recovering the granules, wherein the relative humidity at the tower outlet is chosen in a range of from 5% to 60%; and wherein a cylindrical wall of the lower part forms an angle of α Cy with a wall of the frustoconical chamber, which is arranged at an angle of (α Cy ) relative to a side wall of the cylindrical upper part and the roof of the chamber, and α Cy is equal to 90°. 9. A pulverulent composition comprising the granules according to claim 1 . 10. A process for preparing tablets, consisting essentially of directly compressing the pulverulent composition according to claim 9 . 11. A tablet consisting essentially of the pulverulent composition as defined in claim 9 , prepared in accordance with the process as defined in claim 10 . 12. A tablet essentially free of granular starch, consisting essentially of: 30.0% to 100.0% of the non-spherical granules of microcrystalline mannitol of claim 1 ; greater than 0.1 to less than 0.8% of lubricant; 0% to 70.0% of ingredients other than mannitol and lubricant, wherein the percentages are expressed by dry weight, and their sum being equal to 100%. 13. A process of using a direct compression excipient, comprising providing the granules according to claim 1 and directly compressing the granules to form a tablet.
resulting in granules or microspheres of the matrix type containing more than 5% of excipient · CPC title
Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules · CPC title
Tabletting processes · CPC title
Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates · CPC title
Processes or devices for granulating materials {, e.g. fertilisers} in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.